Is Pfizer Stock a Buy? [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Today, the stock has seemingly settled in the high $20s, near the lows of the past decade. It's time to get the word out: The pessimism on Pfizer stock has gone too far At first glance, Pfizer looks like a money pit, but the stock is more of a table-pounding bargain. Here are three reasons investors should consider snapping up Pfizer as a long-term investment with market-beating potential. 1. This 6% dividend yield is no trap Pfizer has long been a dividend-paying stock and built a solid reputation by raising it for 14 consecutive years. Today, the dividend yield stands out more than the company's growth. Its current 6% yield is the highest outside of the financial crisis in 2008-2009. Sometimes, a high yield can be a red flag, a sign that the market isn't confident in the company's prospects and ability to continue to pay. Given Pfizer's slide, that seems to be the case. However, the market would be wrong. In Pfizer's Q1 earnings call, management clarified that maintainin
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- CDC Narrows Age Recommendation for Use of RSV Vaccine [Yahoo! Finance]Yahoo! Finance
- Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod [Yahoo! Finance]Yahoo! Finance
- Ceftriaxone Industry Research 2024: Effective Treatment of Multi-Drug Resistant Infections Bolsters Growth - Global Forecasts to 2032 [Yahoo! Finance]Yahoo! Finance
- Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline [CNBC]CNBC
- Finland To Start Bird Flu Vaccinations For Humans [zero hedge]zero hedge
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- 6/11/24 - Form 11-K
- PFE's page on the SEC website